Nurse’s research focuses on how cyclin-dependent kinases (CDKs) and their networks control progression through the eukaryotic cell cycle—particularly the onset of S-phase and mitosis—and the regulation of CDKs by cell size and DNA ploidy. These studies are carried out the simple eukaryote, fission yeast.

Nurse is a geneticist and cell biologist who researches how the eukaryotic cell cycle is controlled. The cell cycle is made up of a set of ordered and temporally organized events that ultimately lead to the division of a cell into two daughters, a process fundamental to all life. The goal of his laboratory is to better understand the global cellular networks which regulate the eukaryotic cell cycle using the fission yeast Schizosaccharomyces pombe.

Using genetic screens in the fission yeast, a single-celled eukaryote, his group identified the Cyclin-dependent kinase (CDK1/cdc2) and have shown that its increasing activity acts like a rheostat to control cell cycle progression. This event is coordinated with cell growth so cells divide at a defined size and display cell size homeostasis between divisions.

Nurse expects that these studies in fission yeast will lead to an improved understanding of equivalent controls in human cells, which is important as uncontrolled cell growth and proliferation can lead to diseases such as cancer.

His laboratory at Rockefeller is developing use of fission yeast to investigate how CDK regulates onset and progression through cytokinesis.

Nurse is a faculty member in the David Rockefeller Graduate Program, and the Tri-Institutional M.D.-Ph.D. Program.